Previous close | 1.5500 |
Open | 1.3000 |
Bid | 0.9800 |
Ask | 1.0500 |
Strike | 160.00 |
Expiry date | 2024-06-21 |
Day's range | 1.0300 - 1.4400 |
Contract range | N/A |
Volume | |
Open interest | 8.12k |
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.